UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000058217 |
|---|---|
| Receipt number | R000066559 |
| Scientific Title | Methods for Measuring Postpartum Hemorrhage after Vaginal Delivery by Health Care Professionals: A Scoping Review |
| Date of disclosure of the study information | 2025/06/19 |
| Last modified on | 2025/06/19 09:34:43 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Methods for Measuring Postpartum Hemorrhage after Vaginal Delivery by Health Care Professionals: A Scoping Review
Acronym
Methods for Measuring Postpartum Hemorrhage after Vaginal Delivery by Health Care Professionals: A Scoping Review
Scientific Title
Methods for Measuring Postpartum Hemorrhage after Vaginal Delivery by Health Care Professionals: A Scoping Review
Scientific Title:Acronym
Methods for Measuring Postpartum Hemorrhage after Vaginal Delivery by Health Care Professionals: A Scoping Review
Region
| Japan |
Condition
Condition
Methods for measuring blood loss during vaginal delivery
Classification by specialty
| Obstetrics and Gynecology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Comprehensively investigate methods for measuring blood loss during vaginal delivery and map each measurement method.
Basic objectives2
Others
Basic objectives -Others
Evaluate the reliability and accuracy of the bleeding volume measurement methods mapped to each measurement method.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Map the methods for measuring blood loss during vaginal delivery (visual estimation method, weight method, weighing device method, etc.) and describe the characteristics of each measurement method (measurement tools, reliability and accuracy of measurements, measurers and locations).
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Female
Key inclusion criteria
1) Studies that investigated methods for measuring blood loss during childbirth.
2) Studies that measured blood loss during vaginal delivery.
The following research designs were adopted:
Cohort studies, cross-sectional studies, case series studies, case studies, qualitative studies (interviews, focus groups), and intervention studies (when there were descriptions of methods for measuring blood loss during childbirth).
Key exclusion criteria
1) Duplicate literature
2) Academic conference presentations
3) Methods for measuring blood loss during delivery in cesarean sections
4) Review papers (systematic reviews/meta-analyses, scoping reviews)
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Yurika |
| Middle name | |
| Last name | Saito |
Organization
Mie University
Division name
Graduate School of Medicine
Zip code
514-8507
Address
2-174 Edobashi, Tsu
TEL
0592321111
324d101@m.mie-u.ac.jp
Public contact
Name of contact person
| 1st name | Yurika |
| Middle name | |
| Last name | Saito |
Organization
Mie University
Division name
Graduate School of Medicine
Zip code
510-0884
Address
2-174 Edobashi, Tsu
TEL
0592321111
Homepage URL
324d101@m.mie-u.ac.jp
Sponsor or person
Institute
Mie University
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
N/A
Address
N/A
Tel
N/A
N/A
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 06 | Month | 19 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 06 | Month | 19 | Day |
Date of IRB
Anticipated trial start date
| 2025 | Year | 06 | Month | 25 | Day |
Last follow-up date
| 2027 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Data sources and search strategy
We will systematically search the following electronic databases for all available literature published between the start of the database and April 30, 2025: PubMed, CINAHL, Cochrane Central Register of Controlled Trials in the Cochrane Library, and Ichushi Web, the Japanese Medical Association's medical paper database.
Selection of studies in included studies
Two review authors will independently check to ensure that studies meet the inclusion criteria. Any discrepancies in study selection will be resolved by discussion or discussion with a third author.
Management information
Registered date
| 2025 | Year | 06 | Month | 19 | Day |
Last modified on
| 2025 | Year | 06 | Month | 19 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066559
